<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34829439</PMID><DateRevised><Year>2021</Year><Month>11</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4418</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>12</Day></PubDate></JournalIssue><Title>Diagnostics (Basel, Switzerland)</Title><ISOAbbreviation>Diagnostics (Basel)</ISOAbbreviation></Journal><ArticleTitle>A Strategy to Detect Emerging Non-Delta SARS-CoV-2 Variants with a Monoclonal Antibody Specific for the N501 Spike Residue.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2092</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diagnostics11112092</ELocationID><Abstract><AbstractText>Efforts to control SARS-CoV-2 have been challenged by the emergence of variant strains that have important implications for clinical and epidemiological decision making. Four variants of concern (VOCs) have been designated by the Centers for Disease Control and Prevention (CDC), namely, B.1.617.2 (delta), B.1.1.7 (alpha), B.1.351 (beta), and P.1 (gamma), although the last three have been downgraded to variants being monitored (VBMs). VOCs and VBMs have shown increased transmissibility and/or disease severity, resistance to convalescent SARS-CoV-2 immunity and antibody therapeutics, and the potential to evade diagnostic detection. Methods are needed for point-of-care (POC) testing to rapidly identify these variants, protect vulnerable populations, and improve surveillance. Antigen-detection rapid diagnostic tests (Ag-RDTs) are ideal for POC use, but Ag-RDTs that recognize specific variants have not yet been implemented. Here, we describe a mAb (2E8) that is specific for the SARS-CoV-2 spike protein N501 residue. The 2E8 mAb can distinguish the delta VOC from variants with the N501Y meta-signature, which is characterized by convergent mutations that contribute to increased virulence and evasion of host immunity. Among the N501Y-containing mutants formerly designated as VOCs (alpha, beta, and gamma), a previously described mAb, CB6, can distinguish beta from alpha and gamma. When used in a sandwich ELISA, these mAbs sort these important SARS-CoV-2 variants into three diagnostic categories, namely, (1) delta, (2) alpha or gamma, and (3) beta. As delta is currently the predominant variant globally, they will be useful for POC testing to identify N501Y meta-signature variants, protect individuals in high-risk settings, and help detect epidemiological shifts among SARS-CoV-2 variants.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Puligedda</LastName><ForeName>Rama Devudu</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Center for Human Antibody Technology, Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Saleem</LastName><ForeName>Fetweh H</ForeName><Initials>FH</Initials><AffiliationInfo><Affiliation>Center for Human Antibody Technology, Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wirblich</LastName><ForeName>Cristoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kattala</LastName><ForeName>Chandana Devi</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Center for Human Antibody Technology, Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jović</LastName><ForeName>Marko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nicoya Lifesciences, Kitchener, ON N2G 2K4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geiszler</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Lankenau Medical Center, Wynnewood, PA 19096, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devabhaktuni</LastName><ForeName>Himani</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Human Antibody Technology, Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feuerstein</LastName><ForeName>Giora Z</ForeName><Initials>GZ</Initials><AffiliationInfo><Affiliation>Debina Diagnostics, Newtown Square, PA 19073, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schnell</LastName><ForeName>Matthias J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sack</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pro-SPR, 52477 Alsdorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Livornese</LastName><ForeName>Lawrence L</ForeName><Initials>LL</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Internal Medicine, Lankenau Medical Center, Wynnewood, PA 19096, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dessain</LastName><ForeName>Scott K</ForeName><Initials>SK</Initials><Identifier Source="ORCID">0000-0002-4331-6799</Identifier><AffiliationInfo><Affiliation>Center for Human Antibody Technology, Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>N/A</GrantID><Agency>Sharpe Strumia Reseach Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diagnostics (Basel)</MedlineTA><NlmUniqueID>101658402</NlmUniqueID><ISSNLinking>2075-4418</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">OCMS™</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">clinical diagnostic test</Keyword><Keyword MajorTopicYN="N">delta variant</Keyword><Keyword MajorTopicYN="N">monoclonal antibody</Keyword><Keyword MajorTopicYN="N">variants of concern</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>27</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34829439</ArticleId><ArticleId IdType="pii">diagnostics11112092</ArticleId><ArticleId IdType="doi">10.3390/diagnostics11112092</ArticleId><ArticleId IdType="pmc">PMC8625484</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>ACS Omega. 2021 Jul 27;6(31):20139-20148</Citation><ArticleIdList><ArticleId IdType="pubmed">34373846</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2020 May 8;368(6491):630-633</Citation><ArticleIdList><ArticleId IdType="pubmed">32245784</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2021 Apr 9;372(6538):</Citation><ArticleIdList><ArticleId IdType="pubmed">33658326</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosensors (Basel). 2020 Sep 24;10(10):</Citation><ArticleIdList><ArticleId IdType="pubmed">32987809</ArticleId></ArticleIdList></Reference><Reference><Citation>MAbs. 2019 Apr;11(3):546-558</Citation><ArticleIdList><ArticleId IdType="pubmed">30794061</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Netw Open. 2021 Aug 2;4(8):e2126931</Citation><ArticleIdList><ArticleId IdType="pubmed">34448871</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2015 Jan;89(1):144-54</Citation><ArticleIdList><ArticleId IdType="pubmed">25320306</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2021 May;593(7857):130-135</Citation><ArticleIdList><ArticleId IdType="pubmed">33684923</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2021 May 27;184(11):2939-2954.e9</Citation><ArticleIdList><ArticleId IdType="pubmed">33852911</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2021 Jun;26(24):</Citation><ArticleIdList><ArticleId IdType="pubmed">34142653</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosci Trends. 2021 May 11;15(2):93-99</Citation><ArticleIdList><ArticleId IdType="pubmed">33776018</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2021 Jul 13;54(7):1611-1621.e5</Citation><ArticleIdList><ArticleId IdType="pubmed">34166623</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Genet Evol. 2021 Nov;95:105038</Citation><ArticleIdList><ArticleId IdType="pubmed">34403832</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Microbiol. 2021 Sep;6(9):1188-1198</Citation><ArticleIdList><ArticleId IdType="pubmed">34400835</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2021 Apr 29;184(9):2372-2383.e9</Citation><ArticleIdList><ArticleId IdType="pubmed">33743213</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2020 Aug;584(7819):120-124</Citation><ArticleIdList><ArticleId IdType="pubmed">32454512</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2021 Apr 29;19(4):e3001237</Citation><ArticleIdList><ArticleId IdType="pubmed">33914735</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2021 Oct 11;:</Citation><ArticleIdList><ArticleId IdType="pubmed">34634791</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2017 Oct 4;35(41):5455-5462</Citation><ArticleIdList><ArticleId IdType="pubmed">28343771</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Microbe. 2021 Sep;2(9):e461-e471</Citation><ArticleIdList><ArticleId IdType="pubmed">34226893</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Virol. 2021 Aug;49:111-116</Citation><ArticleIdList><ArticleId IdType="pubmed">34116392</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Microbiol. 2021 Jul;19(7):409-424</Citation><ArticleIdList><ArticleId IdType="pubmed">34075212</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2021 Mar 24;3:CD013705</Citation><ArticleIdList><ArticleId IdType="pubmed">33760236</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2021 Jan;26(3):</Citation><ArticleIdList><ArticleId IdType="pubmed">33478625</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxins (Basel). 2017 May 19;9(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">28534855</ArticleId></ArticleIdList></Reference><Reference><Citation>Hybridoma (Larchmt). 2008 Feb;27(1):11-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18294071</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2021 Jul;22(7):415-426</Citation><ArticleIdList><ArticleId IdType="pubmed">33948037</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2020 Apr 16;181(2):281-292.e6</Citation><ArticleIdList><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2021 May 7;19(5):e3001236</Citation><ArticleIdList><ArticleId IdType="pubmed">33961632</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2021 Dec;22(12):757-773</Citation><ArticleIdList><ArticleId IdType="pubmed">34535792</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Protoc. 2018 Jan;13(1):99-117</Citation><ArticleIdList><ArticleId IdType="pubmed">29240734</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2021 Mar 19;12(1):1739</Citation><ArticleIdList><ArticleId IdType="pubmed">33741959</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2021 May 12;29(5):747-751.e4</Citation><ArticleIdList><ArticleId IdType="pubmed">33887205</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2020 Feb 21;11(1):1007</Citation><ArticleIdList><ArticleId IdType="pubmed">32081907</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2021 Nov 2;73(9):e2861-e2866</Citation><ArticleIdList><ArticleId IdType="pubmed">33479756</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol Methods. 2008 Jan 1;329(1-2):112-24</Citation><ArticleIdList><ArticleId IdType="pubmed">17996249</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2021 Apr 15;184(8):2201-2211.e7</Citation><ArticleIdList><ArticleId IdType="pubmed">33743891</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2021 Sep 30;184(20):5189-5200.e7</Citation><ArticleIdList><ArticleId IdType="pubmed">34537136</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2021 Nov 3;:</Citation><ArticleIdList><ArticleId IdType="pubmed">34731554</ArticleId></ArticleIdList></Reference><Reference><Citation>Cold Spring Harb Protoc. 2011 Jun 01;2011(6):695-715</Citation><ArticleIdList><ArticleId IdType="pubmed">21632778</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosens Bioelectron. 2021 Jan 1;171:112715</Citation><ArticleIdList><ArticleId IdType="pubmed">33099241</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Nanomedicine. 2020 Oct 07;15:7583-7599</Citation><ArticleIdList><ArticleId IdType="pubmed">33116489</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Adv. 2021 Jan 1;7(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">33219112</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2021 Apr 14;29(4):508-515</Citation><ArticleIdList><ArticleId IdType="pubmed">33789086</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2020 Mar;579(7798):265-269</Citation><ArticleIdList><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2021 Sep;21(9):e290-e295</Citation><ArticleIdList><ArticleId IdType="pubmed">33636148</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>